Vaccine News and Research

Latest Vaccine News and Research

Wistar researcher receives NIH Director's Award to study link between diet, alcohol use and cancer

The National Institutes of Health today announced that Zachary T. Schug, Ph.D., assistant professor in the Molecular & Cellular Oncogenesis Program at The Wistar Institute, was awarded the prestigious NIH Director's New Innovator Award in support of his research on the link between a high sugar/fat diet, alcohol use and cancer.

1 Oct 2019

Mount Sinai researchers receive NIH award to develop universal flu vaccine

Researchers at the Icahn School of Medicine at Mount Sinai have received a contract award of up to $132 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), as part of a new Collaborative Influenza Vaccine Innovation Centers (CIVICs) program to further develop the universal flu vaccine.

1 Oct 2019

NIAID initiates new Collaborative Influenza Vaccine Innovation Centers program

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has initiated the Collaborative Influenza Vaccine Innovation Centers program, a new network of research centers that will work together in a coordinated, multidisciplinary effort to develop more durable, broadly protective and longer-lasting influenza vaccines.

30 Sep 2019

University of Georgia signs contract with NIH to develop advanced influenza vaccine

The University of Georgia has signed a contract with the National Institutes of Health for an initial award of $8 million to develop a new, more advanced influenza vaccine designed to protect against multiple strains of influenza virus in a single dose.

30 Sep 2019

Infectious disease experts explain how to stay healthy during the flu season

About 40 million people contracted the flu last year, with hundreds of thousands hospitalized and 35,400 to 61,000 deaths, including 134 children, according to the Centers for Disease Control and Prevention.

30 Sep 2019

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases, with an initial award of approximately $29.6 million in first-year funding.

30 Sep 2019

UK government considers compulsory immunization for all school children

Immunization efforts have been implemented across the globe. But, the rates of immunized children are dropping. In the United Kingdom, health officials have expressed alarms the drop in take-up of routine childhood vaccinations, leaving thousands of children under-protected from 13 different diseases.

30 Sep 2019

Scientists discover T cell homing beacons for lungs

Scientists have identified a pair of molecules critical for T cells, part of the immune system, to travel to and populate the lungs. A potential application could be strengthening vaccines against respiratory pathogens such as influenza.

27 Sep 2019

Cancer Research Institute declares 2019 recipients of top scientific and philanthropic awards

The Cancer Research Institute (CRI), a nonprofit organization dedicated to advancing the discovery and development of powerful immunotherapies for all forms of cancer, has announced the 2019 recipients of its highest scientific and philanthropic awards.

27 Sep 2019

NIH awards $30 million to accelerate progress in TB vaccine development

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded $30 million in first-year funding to establish new centers for immunology research to accelerate progress in tuberculosis vaccine development.

26 Sep 2019

Closure of women's health clinics linked to lower cervical cancer screening and higher mortality

Following the closure of nearly 100 women's health clinics across the United States from 2010 to 2013, fewer women were screened for cervical cancer, more women were diagnosed with advanced stages of the disease and mortality rates rose.

26 Sep 2019

BCG vaccination in childhood could decrease risk of lung cancer

A common tuberculosis vaccine could decrease the risk of lung cancer if administered during early childhood, according to a study published Sept. 25 in JAMA Network Online.

25 Sep 2019

Second round of Ebola vaccination trials on the way to DRC

A second experimental Ebola vaccine made by Johnson & Johnson will soon undergo clinical trials in the Ebola affected Democratic Republic of the Congo (DRC) announced health officials. The second round of vaccinations is to begin middle of October this year.

24 Sep 2019

Wistar awarded more than $12 million to study opioid use in HIV-infected people

The Wistar Institute was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse, part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by Wistar's HIV Research Program.

24 Sep 2019

The biological clock modulates immune response efficiency, study shows

According to a recent study published in Proceedings of the National Academy of Sciences of the United States of America, the biological clock influences immune response efficacy. Indeed, CD8 T cells, which are essential to fight infections and cancers, function very differently according to the time of day.

24 Sep 2019

Advancing towards 100% effective herpes vaccine

Genital herpes, caused by the herpes simplex virus 2 (HSV-2) is a very common sexually transmitted infection (STI). It affects 14% of Americans aged 15-49 years. There is no herpes vaccine at present. Many failed attempts at vaccine production have centered around HSV proteins.

23 Sep 2019

Vaccine News and Research

Latest Vaccine News and Research

Wistar researcher receives NIH Director's Award to study link between diet, alcohol use and cancer

Mount Sinai researchers receive NIH award to develop universal flu vaccine

NIAID initiates new Collaborative Influenza Vaccine Innovation Centers program

University of Georgia signs contract with NIH to develop advanced influenza vaccine

Infectious disease experts explain how to stay healthy during the flu season

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

UK government considers compulsory immunization for all school children

Scientists discover T cell homing beacons for lungs

Cancer Research Institute declares 2019 recipients of top scientific and philanthropic awards

NIH awards $30 million to accelerate progress in TB vaccine development

Closure of women's health clinics linked to lower cervical cancer screening and higher mortality

BCG vaccination in childhood could decrease risk of lung cancer

Second round of Ebola vaccination trials on the way to DRC

Wistar awarded more than $12 million to study opioid use in HIV-infected people

The biological clock modulates immune response efficiency, study shows

Advancing towards 100% effective herpes vaccine

IDSA calls for meaningful funding to control current Ebola outbreak

Tanzania keeping Ebola under wraps

2019 ASTMH Annual Meeting to focus on Ebola, monkey malaria, and other infectious diseases

Mutations in specific protein make dengue virus resistant to vaccines and therapeutics

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in